Company & Sponsor Intelligence

Imperial College London

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials5

Recruiting3

Completed0

Countries2

Therapeutic footprint

alzheimersother_neurologystroke

Indexed studies

NCT07705256EMG-Directed Virtual-Reality Training for Motor Stroke Rehabilitation
stroke · United KingdomNA

NCT01843075Evaluating Liraglutide in Alzheimer's Disease
alzheimers · United KingdomPHASE2

NCT02874820I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD
alzheimers · United KingdomEARLY_PHASE1

NCT05395195Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
other_neurology · BangladeshPHASE3

NCT07401849Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care
alzheimers · NOT_YET_RECRUITING

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →